Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of a monoclonal antibody therapy for progressive small cell lung cancer has completed recruitment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2022-02-08